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Background
Lysozymes are antibacterial proteins defined by their abil-
ity to hydrolyse beta-1,4-glycosidic linkage between
N-acetylmuramic acid and N-acetylglucosamine of pepti-
doglycan in the cell wall of bacteria [1]. In the recent
years, little evidence on their involvement in malaria
pathogenesis has emerged. In Anopheles gambiae and
stephensi, lysozyme was shown to bind to oocysts of
Plasmodium berghei and falciparum, thereby facilitating
their development within the mosquito [2]. In human
patients, lysozyme plasma levels correlated significantly to
parasitaemia degree, suggesting its potential role as marker
of disease severity [3]. In this context, phagocytosis of hae-
mozoin (HZ, malarial pigment) was shown in a previous
work to induce in vitro lysozyme release from human
monocytes [4]; here, the underlying mechanisms were
investigated.
Materials and methods
Human adherent monocytes from healthy donors were
allowed to phagocytose for 2 h natural HZ isolated from
Plasmodium falciparum cultures; after the end of phago-
cytosis, cells were incubated for 2 additional h in the pre-
sence or absence of: anti-TNFalpha/IL-1beta/MIP-1alpha
blocking antibodies; recombinant TNFalpha/IL-1beta/
MIP-1alpha; p38 MAPK inhibitor (SB203580); NF-kappaB
inhibitors (quercetin, artemisinin, and parthenolide).
Thereafter, lysozyme levels in cell supernatants were eval-
uated by measuring lysis of Mycrococcus Lysodeikticus sus-
pensions through spectrometry, and TNFalpha, IL-1beta,
and MIP-1alpha levels by ELISA. In cell lysates, p38
MAPK and NF-kappaB pathways were investigated by
Western blotting or EMSA.
Results
HZ promoted a time-dependent release of lysozyme,
along with TNFalpha, IL-1beta and MlP-1alpha. HZ-
induced lysozyme release was abrogated by anti-TNFal-
pha/IL-1beta/MIP-1alpha blocking antibodies, and
mimicked by all three recombinant cytokines. Moreover,
HZ early activated either p38 MAPK or NF-kappaB
pathways by inducing: p38 MAPK phosphorylation;
cytosolic I-kappaBalpha phosphorylation and degrada-
tion; NF-kappaB nuclear translocation and DNA-bind-
ing. Inhibition of both routes prevented HZ-dependent
lysozyme release.
Conclusions
These data suggest that the HZ-triggered overproduction
of TNFalpha, IL-1beta and MlP-1alpha mediates induction
of lysozyme release from human monocytes through acti-
vation of p38 MAPK and NF-kappaB pathways. Therefore,
the present work provides new evidence on the mechan-
isms underlying HZ-enhanced monocyte degranulation in
falciparum malaria, supporting the hypothesis that lyso-
zyme could be used as a new affordable marker in severe
malaria.
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